Two investment firms have acquired large stakes in global CRO Novotech, the Singapore-based company announced March 30. GIC ...

Since TPG’s investment in 2017, the firm has raised its headcount tenfold to 3,000 employees and expanded its operations ...

The two sovereign wealth funds have taken a “significant stake” in the clinical research business owned by the private equity ...

SYDNEY, March 31, 2025--(BUSINESS WIRE)--Novotech, a globally recognized full-service biotech specialist clinical research organization (CRO), announced today that affiliates of GIC and Temasek ...

Temasek Holdings Pte and GIC Pte Ltd. will acquire a significant stake in Novotech Pty Ltd. to fuel growth and accelerate ...

Novotech, a top global clinical trial provider, partners with biotech and pharma to speed siRNA therapeutic development.

Novotech, a globally recognized full-service biotech specialist clinical research organization (CRO), announced today that affiliates of GIC and Temasek have signed binding agreements to acquire a ...

Novotech provides biotech to small and mid-sized pharma companies. GIC and Temasek have signed a binding agreement to acquire ...

SINGAPORE] Clinical research and testing provider Novotech on Monday (Mar 31) announced that Temasek and GIC will acquire a ...